Anne-Kathrin Witt

Anne-Kathrin Witt is an accomplished professional in strategic management and corporate development with extensive experience in the pharmaceutical and healthcare industries. Currently serving as the Enterprise Head of Strategy & Corporate Development at CSL since January 2024, Anne-Kathrin previously held the position of Principal at Boston Consulting Group, where involvement as a member of the Health Care Practice Leadership Team was noted. A significant tenure at Novartis spanned from 2014 to 2022, culminating in the role of VP, Global Head Digital BD&L, alongside various leadership positions in business development and strategic operations. Other notable roles include Associate Director of Global CNS Strategic Marketing at Teva Pharmaceuticals and Senior Consultant at PwC, specializing in strategy and corporate finance advisory for the pharmaceutical sector. Anne-Kathrin's educational background features an MBA from Harvard Business School and a Master of Science from Ludwig-Maximilians-Universität München, complemented by a Bachelor of Arts and Science degree from Wesleyan College.